Bioregenx (BRGX) EBIT Margin (2022 - 2026)
Bioregenx (BRGX) recorded quarterly EBIT Margin of 11.68% in Q1 2026, up 95.19% quarter-over-quarter from 242.62% in Q4 2025, and up 2571.0% on a YoY basis from 0.44% in Q1 2025.
Bioregenx (BRGX) EBIT Margin (2022 - 2026) Analysis & Trends
Bioregenx's EBIT Margin history runs 5 years deep, the most recent figure standing at 11.68% for Q1 2026.
- In Q1 2026, EBIT Margin rose 2571.0% year-over-year to 11.68%; the TTM figure through Mar 2026 stood at 62.37% (up 79969.0% YoY), while the FY2025 annual figure was 67.08%, up 90567.0% from the prior year.
- EBIT Margin was 11.68% for Q1 2026 at Bioregenx, up from 242.62% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 1.67% in Q3 2025 to a low of 3977.69% in Q4 2024.
- Historically, EBIT Margin has averaged 369.02% across 5 years, with a median of 62.09% in 2022.
- The sharpest annual moves came in 2024 and 2025: EBIT Margin slumped 394649 bps in 2024, then soared 373506 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 62.09% in 2022, then jumped by 50 bps to 31.2% in 2023, then slumped by 12648 bps to 3977.69% in 2024, then jumped by 94 bps to 242.62% in 2025, then soared by 95 bps to 11.68% in 2026.
- The last three EBIT Margin figures came in at 11.68% (Q1 2026), 242.62% (Q4 2025), and 1.67% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 17.59% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -11.30% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 17.08% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 25.64% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.23% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 5.44% |
| 10 | Bioregenx | - | - | 348,288.00 | -11.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.68% |
| Dec 31, 2025 | -242.62% |
| Sep 30, 2025 | -1.67% |
| Jun 30, 2025 | -24.05% |
| Mar 31, 2025 | -37.39% |
| Dec 31, 2024 | -3,977.69% |
| Sep 30, 2024 | -54.91% |
| Jun 30, 2024 | -141.66% |
| Mar 31, 2024 | -560.36% |
| Dec 31, 2023 | -31.20% |
| Sep 30, 2023 | -310.69% |
| Jun 30, 2023 | -63.09% |
| Mar 31, 2023 | -17.12% |
| Dec 31, 2022 | -62.09% |
| Sep 30, 2022 | -19.42% |
| Jun 30, 2022 | -233.29% |
| Mar 31, 2022 | -484.41% |